Multiple Granulocytic Sarcomas in Essential Thrombocythemia


A 59-year-old woman was diagnosed with essential thrombocythemia in 1988 and had been treated with hydroxyurea, mitobronitol, busulfan, and ranimustine, in that order. Hepatosplenomegaly, low-grade fever, and body weight loss manifested, and a few blasts were noted in the peripheral blood studied in March 2002. A biopsied specimen of the bone marrow showed myelofibrosis but not a leukemia in August 2004. An abnormal karyotype with der(1;13) appeared for the first time. She was treated with low-dose prednisolone. In January 2005, she experienced left hip joint pain, and magnetic resonance scanning showed a tumoral lesion in the femoral head. Histological diagnosis of the biopsied mass revealed that it was a granulocytic sarcoma, and radiotherapy was performed. In April 2005, bone scintigraphy showed multiple lesions. She became febrile and red blood cell transfusion-dependent with hepatosplenomegaly and a small number of circulating blasts. Intravenous cytarabine (low dose) and etoposide relieved the fever and hepatosplenomegaly; however, she developed a pathologic fracture of the right humerus.An additional karyotypic abnormality (7q22 deletion) was noted. She subsequently died of infection. Granulocytic sarcoma is very rare in essential thrombocythemia, and this patient may be the first reported case of essential thrombocythemia that developed multiple lesions and a pathologic fracture without transformation to overt leukemia.

This is a preview of subscription content, log in to check access.


  1. 1.

    Cristolini A, Mazzucconi MG, Ferrari A, et al. Essential thrombo-cythemia: a retrospective study on the clinical course of 100 patients. Hematologica. 1990;75:537–540.

    Google Scholar 

  2. 2.

    Fenaux P, Simon M, Caulier MT, et al. Clinical course of essential thrombocythemia in 147 cases. Cancer. 1990;66:549–556.

    Article  CAS  PubMed  Google Scholar 

  3. 3.

    Hehlman R, Jahn M, Bauman B, et al. Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer. 1988;61:2487–2496.

    Article  Google Scholar 

  4. 4.

    Hattori A, Nagayama R, Kishi K, et al. Primary thrombocythemia in Japan: a survey of 225 patients. Leuk Lymphoma. 1990;4:177–186.

    Article  Google Scholar 

  5. 5.

    Shibata K, Shimamoto Y, Suga K, Sano M, Matsuzaki M, Yamaguchi M. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation—a brief review of recent literature. Acta Haematol. 1994;91:84–88.

    Article  CAS  PubMed  Google Scholar 

  6. 6.

    Burns A. Observations of surgical anatomy. In: Head and Neck. London, England: Royce; 1811:364.

    Google Scholar 

  7. 7.

    Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology, Section III, Fascicle 8. Washington, DC: Armed Forces Institute of Pathology; 1967:241–247.

    Google Scholar 

  8. 8.

    Byrd BC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800–1816.

    CAS  PubMed  Google Scholar 

  9. 9.

    Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48:1426–1437.

    Article  CAS  PubMed  Google Scholar 

  10. 10.

    Au WY, Shek TW, Ma SK, et al. Myeloblastoma (chloroma) in leukemia: case 2. Meningeal granulocytic sarcoma (chloroma) in essential thrombocythemia. J Clin Oncol. 2000;18:3996–3997.

    CAS  PubMed  Google Scholar 

  11. 11.

    Grande M. Central nervous system granulocytic sarcoma in a patient with essential thrombocythemia. Am J Hematol. 1996;51:64–67.

    Article  CAS  PubMed  Google Scholar 

  12. 12.

    Hamadani M, Tfayli A, Sethi S, Awab A, Hamdani N. Granulocytic sarcoma manifesting as multiple skeletal lesions. Am J Med Sci. 2005;330:139–43.

    Article  PubMed  Google Scholar 

  13. 13.

    Whang-Peng BJ, Young RC, Lee EC, et al. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood. 1988;71:403–414.

    CAS  PubMed  Google Scholar 

  14. 14.

    Le Beau MM, Albain KS, Larsen RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndrome and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes nos. 5 and 7. J Clin Oncol. 1986;4:325–345.

    CAS  PubMed  Google Scholar 

  15. 15.

    Sterkers Y, Predhomme C, Laü J-L, et al. Acute leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood. 1998;91:616–622.

    CAS  PubMed  Google Scholar 

  16. 16.

    Finazzi G, Barbui T. Efficacy and safety of hydroxyurea in patients with essential thrombocythemia. Pathol Biol. 2001;49:167–169.

    Article  CAS  PubMed  Google Scholar 

  17. 17.

    Hsiao HH, Ito Y, Sashida G, et al. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia. Leuk Res. 2005;29:1247–1252.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information



Corresponding authors

Correspondence to Yasuhiro Tanaka or Yuya Nagai or Minako Mori or Haruyuki Fujita or Katsuhiro Togami or Masayuki Kurata or Akiko Matsushita or Akinori Maeda or Kenichi Nagai or Kyoko Tanaka or Takayuki Takahashi.

About this article

Cite this article

Tanaka, Y., Nagai, Y., Mori, M. et al. Multiple Granulocytic Sarcomas in Essential Thrombocythemia. Int J Hematol 84, 413–416 (2006).

Download citation

Key words

  • Granulocytic sarcoma
  • Essential thrombocythemia
  • Pathologic fracture
  • 7q22 Deletion
  • Alkylating agent